A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Recurrent/Metastatic Head and Neck Cancers
Condition(s):Recurrent Head and Neck Cancer; Metastatic Head and Neck CancerLast Updated:March 7, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Recurrent Head and Neck Cancer; Metastatic Head and Neck CancerLast Updated:March 7, 2024Completed
Condition(s):Platinum-resistant Ovarian CancerLast Updated:March 7, 2024Terminated
Condition(s):Treatment; Peripheral T-cell LymphomaLast Updated:July 1, 2022Recruiting
Condition(s):Advanced Solid TumorLast Updated:November 1, 2021Active, not recruiting
Condition(s):Relapsed or Refractory Acute Myeloid Leukemia (AML)Last Updated:February 23, 2024Terminated
Condition(s):Diffuse Large B-Cell LymphomaLast Updated:February 8, 2024Recruiting
Condition(s):Recurrent/Refractory LymphomaLast Updated:December 30, 2021Completed
Condition(s):Advanced Pancreatic CancerLast Updated:October 29, 2021Not yet recruiting
Condition(s):Extranodal Natural Killer T Cell LymphomaLast Updated:July 19, 2022Recruiting
Condition(s):Unresectable or Metastatic Bone and Soft Tissue SarcomaLast Updated:March 7, 2024Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.